Clinical trial

Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)

NCT03345810

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Durvalumab Normalized identity: durvalumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vinorelbine Normalized identity: vinorelbineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention nab-Paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-12-14

PhasePHASE2

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Metastatic Lung Cancerunresolved

Non Small Cell Lung Cancerunresolved

Lung Adenocarcinoma Metastaticunresolved

Large Cell Lung Carcinoma Metastaticunresolved

Interventions

DurvalumabDRUG · verified · RxNorm: durvalumab

VinorelbineDRUG · verified · RxNorm: vinorelbine

GemcitabineDRUG · verified · RxNorm: gemcitabine

nab-PaclitaxelDRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

AIO-Studien-gGmbHlead sponsor

AstraZenecacollaborator

Celgenecollaborator

Mapped research locations

BerlinGermany1 MünchenGermany1 DresdenGermany1 LeipzigGermany1 HeidelbergGermany1 CologneGermany1 UlmGermany1 WürzburgGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03345810 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.